We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Assistant Cell Image Analyzer for Hematology Labs Released

By LabMedica International staff writers
Posted on 19 Jul 2012
AACC 2012: A cell image analyzer for hematology laboratories automates and simplifies the cell differential process by locating and preclassifying white blood cells.

Called EasyCell and manufactured by Medica Corporation (Bedford, MA, USA), the analyzer employs optical pattern recognition software to automatically locate white cells on a blood smear. More...
It digitally stores their images, preclassifies, and then presents them for review—grouped by cell type—on a liquid crystal display (LCD) display.

The analyzer also presents images of red cells and platelets, enabling red cell morphology and platelet estimates. With its 30-position carousel, the EasyCell offers walkaway operation and a stat slide port permits immediate testing without disrupting a sample run.

EasyCell reduces sample review times by 50% over the manual differentiation process using microscopes, while helping the technologist achieve improved efficiency, accuracy, and precision.

Doug Moe, vice president of business development, Medica Corporation, said, “The EasyCell assistant lowers cost by substantially cutting the time technologists require to perform manual blood cell differentials and correctly classify normal cells."

A clinical evaluation at the Children’s Hospital Boston (Boston, MA, USA) confirmed the EasyCell efficacy in the hematology laboratory environment.

In an announcement at the 2012 Annual Meeting of the American Association for Clinical Chemistry (AACC) Expo being held July 15-19, 2012 in Los Angeles (CA, USA), the company said it is now accepting orders for the EasyCell solution and will have instruments available for global shipment during the third quarter of 2012.

Related Links:

Medica Corporation
Children’s Hospital Boston




Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.